India markets closed

Inogen, Inc. (INGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
79.77+0.33 (+0.42%)
At close: 4:00PM EDT
79.77 0.00 (0.00%)
After hours: 04:03PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close79.44
Open79.40
Bid79.61 x 800
Ask83.64 x 800
Day's range78.61 - 80.31
52-week range26.57 - 80.31
Volume119,782
Avg. volume137,771
Market cap1.786B
Beta (5Y monthly)0.92
PE ratio (TTM)N/A
EPS (TTM)-0.23
Earnings date04-Aug-2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est69.00
  • Business Wire

    Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021

    GOLETA, Calif., July 14, 2021--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

  • Business Wire

    Inogen Announces Appointment of General Counsel

    GOLETA, Calif., Jun 21, 2021--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.

  • Business Wire

    Inogen Announces Appointment of Chief Medical Officer

    Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Dr. Stanislav Glezer as Inogen’s Executive Vice President and Chief Medical Officer, effective June 21, 2021.